Medicus Pharma (MDCX)
0.37
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 424B3 Medicus Pharma Ltd.
June 4, 2026 5:04 PM - SEC Filing
Form 8-K Medicus Pharma Ltd. For: Jun 03
June 4, 2026 4:31 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Smith Andrew Alasdair
June 4, 2026 4:20 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Rodgers Cathy McMorris
June 4, 2026 4:18 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Raju Ajay
June 4, 2026 4:17 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Mehmud Faisal
June 4, 2026 4:15 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: May Sara R.
June 4, 2026 4:13 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: MAHAFFY PATRICK J
June 4, 2026 4:13 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Kaiser Larry
June 4, 2026 4:11 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: FISHMAN BARRY
June 4, 2026 4:09 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Ciaruffoli Robert J.
June 4, 2026 4:08 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Brennan Edward J.
June 4, 2026 4:06 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Bonner Carolyn F.
June 4, 2026 4:04 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Bokhari Raza
June 4, 2026 4:02 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Ashton William
June 4, 2026 4:00 PM - SEC Filing
Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome
June 3, 2026 8:00 AM - StreetInsider
New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commoditie
May 30, 2026 11:55 AM - StreetInsider
Medicus Pharma secures $22 million structured financing facility
May 28, 2026 8:06 AM - StreetInsider
Medicus Pharma Announces $22 Million Non-Dilutive Financing
May 28, 2026 8:00 AM - StreetInsider
Form 424B3 Medicus Pharma Ltd.
May 28, 2026 6:02 AM - SEC Filing
Form 8-K Medicus Pharma Ltd. For: May 20
May 27, 2026 4:45 PM - SEC Filing
New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, a
May 23, 2026 12:25 PM - StreetInsider
New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas,
May 16, 2026 7:05 AM - StreetInsider
Medicus Pharma Ltd. (MDCX) Tops Q1 EPS by 30c
May 14, 2026 5:28 PM - StreetInsider
Form 424B3 Medicus Pharma Ltd.
May 14, 2026 4:50 PM - SEC Filing
Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026 4:30 PM - StreetInsider
Form 10-Q Medicus Pharma Ltd. For: Mar 31
May 14, 2026 4:08 PM - SEC Filing
New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN)
May 9, 2026 12:55 PM - StreetInsider
Medicus Pharma reports positive dose response in skin cancer trial
May 6, 2026 7:30 AM - StreetInsider
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response
May 6, 2026 7:30 AM - Globe NewsWire
Form SCHEDULE 13G/A Medicus Pharma Ltd. Filed by: Raju Ajay
May 5, 2026 10:55 AM - SEC Filing
Form ARS Medicus Pharma Ltd. For: Dec 31
May 4, 2026 4:36 PM - SEC Filing
Form DEF 14A Medicus Pharma Ltd. For: Jun 03
May 4, 2026 6:03 AM - SEC Filing
GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households Worldwide
May 1, 2026 2:30 PM - StreetInsider
Form 424B3 Medicus Pharma Ltd.
April 30, 2026 6:15 AM - SEC Filing
Form 10-K/A Medicus Pharma Ltd. For: Dec 31
April 29, 2026 5:21 PM - SEC Filing
Medicus Pharma CEO meets with House lawmakers on rare disease treatment
April 27, 2026 7:39 AM - StreetInsider
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
April 27, 2026 7:38 AM - StreetInsider
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
April 27, 2026 7:30 AM - Globe NewsWire
Form 424B3 Medicus Pharma Ltd.
April 27, 2026 6:02 AM - SEC Filing
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global
April 25, 2026 12:55 PM - StreetInsider
Form 8-K Medicus Pharma Ltd. For: Apr 21
April 24, 2026 5:27 PM - SEC Filing
Form 424B3 Medicus Pharma Ltd.
April 23, 2026 7:00 PM - SEC Filing
Form PRE 14A Medicus Pharma Ltd. For: Jun 03
April 21, 2026 6:05 AM - SEC Filing
Roth/MKM Starts Medicus Pharma Ltd. (MDCX) at Buy
April 21, 2026 3:56 AM - StreetInsider
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Gro
April 18, 2026 10:00 AM - StreetInsider
Medicus Pharma seeks orphan drug status for SkinJect in Gorlin syndrome
April 17, 2026 7:31 AM - StreetInsider
Medicus Pharma Submits Orphan Drug Designation Application to U.S. FDA for SkinJect® in Gorlin Syndrome
April 17, 2026 7:30 AM - Globe NewsWire
Medicus Pharma to Present New Teverelix Data at AACE 2026 Demonstrating Long-Acting Hormone Suppression
April 15, 2026 7:30 AM - StreetInsider
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:
April 11, 2026 12:30 PM - StreetInsider
New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms
April 7, 2026 8:41 AM - StreetInsider
Medicus Pharma submits optimized Phase 2 study for Teverelix to FDA
April 6, 2026 7:31 AM - StreetInsider
Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention
April 6, 2026 7:30 AM - Globe NewsWire
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Smith Andrew Alasdair
April 1, 2026 7:23 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Rodgers Cathy McMorris
April 1, 2026 7:20 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Raju Ajay
April 1, 2026 7:19 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Mehmud Faisal
April 1, 2026 7:17 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: May Sara R.
April 1, 2026 7:16 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: MAHAFFY PATRICK J
April 1, 2026 7:14 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Kaiser Larry
April 1, 2026 7:13 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: FISHMAN BARRY
April 1, 2026 7:11 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Ciaruffoli Robert J.
April 1, 2026 7:10 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Brennan Edward J.
April 1, 2026 7:09 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Bonner Carolyn F.
April 1, 2026 7:07 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Bokhari Raza
April 1, 2026 7:06 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Mar 30 Filed by: Ashton William
April 1, 2026 7:04 PM - SEC Filing
Medicus Pharma clarifies positive SkinJect phase 2 trial data
April 1, 2026 7:30 AM - StreetInsider
Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset
April 1, 2026 7:30 AM - StreetInsider
Medicus Pharma Ltd. (MDCX) PT Lowered to $9 at D. Boral Capital on dilution expectations
March 30, 2026 8:55 AM - StreetInsider
Medicus Pharma reports validation of SkinJect skin cancer trial data
March 30, 2026 7:30 AM - StreetInsider
Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
March 30, 2026 7:30 AM - StreetInsider
Form EFFECT Medicus Pharma Ltd.
March 30, 2026 6:08 AM - SEC Filing
Form EFFECT Medicus Pharma Ltd.
March 30, 2026 6:08 AM - SEC Filing
Form EFFECT Medicus Pharma Ltd.
March 30, 2026 6:08 AM - SEC Filing
Medicus Pharma reports 80% response rate in skin cancer study
March 26, 2026 7:30 AM - StreetInsider
Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
March 26, 2026 7:30 AM - StreetInsider
Form POS AM Medicus Pharma Ltd.
March 25, 2026 5:13 PM - SEC Filing
Form POS AM Medicus Pharma Ltd.
March 25, 2026 5:10 PM - SEC Filing
Form POS AM Medicus Pharma Ltd.
March 25, 2026 5:06 PM - SEC Filing
Form 424B3 Medicus Pharma Ltd.
March 25, 2026 4:53 PM - SEC Filing
Form 424B3 Medicus Pharma Ltd.
March 25, 2026 4:52 PM - SEC Filing
Form 424B3 Medicus Pharma Ltd.
March 25, 2026 4:52 PM - SEC Filing
Form 424B3 Medicus Pharma Ltd.
March 25, 2026 4:50 PM - SEC Filing
Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update
March 25, 2026 4:30 PM - StreetInsider
Form 10-K Medicus Pharma Ltd. For: Dec 31
March 25, 2026 4:09 PM - SEC Filing
Medicus Pharma to discuss phase 2 results in investor fireside chat
March 18, 2026 7:30 AM - StreetInsider
Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst
March 18, 2026 7:30 AM - StreetInsider
Medicus Pharma schedules webcast with Phase 2 trial investigator
March 16, 2026 7:30 AM - StreetInsider
Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webca
March 16, 2026 7:30 AM - StreetInsider
New to The Street Episode #737 Airs on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM EST
March 14, 2026 12:00 PM - StreetInsider
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum
March 10, 2026 7:30 AM - StreetInsider
Medicus Pharma reports 73% clearance rate in basal cell carcinoma trial
March 9, 2026 7:30 AM - StreetInsider
Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset
March 9, 2026 7:30 AM - StreetInsider
New to The Street Broadcasts Tonight on Bloomberg Television at 6:30 PM EST - Shows 736, 737 and 738 Air Across the U.S., Latin America and MENA
March 7, 2026 11:45 AM - StreetInsider
Full Article List
